< Back to Publications
Programmable repression and activation of bacterial gene expression using an engineered CRISPR-Cas system.
|Publication Type||Journal Article|
|Authors||Bikard, D., Jiang W., Samai P., Hochschild A., Zhang F., and Marraffini LA|
|Abstract||The ability to artificially control transcription is essential both to the study of gene function and to the construction of synthetic gene networks with desired properties. Cas9 is an RNA-guided double-stranded DNA nuclease that participates in the CRISPR-Cas immune defense against prokaryotic viruses. We describe the use of a Cas9 nuclease mutant that retains DNA-binding activity and can be engineered as a programmable transcription repressor by preventing the binding of the RNA polymerase (RNAP) to promoter sequences or as a transcription terminator by blocking the running RNAP. In addition, a fusion between the omega subunit of the RNAP and a Cas9 nuclease mutant directed to bind upstream promoter regions can achieve programmable transcription activation. The simple and efficient modulation of gene expression achieved by this technology is a useful asset for the study of gene networks and for the development of synthetic biology and biotechnological applications.|
|Year of Publication||2013|
|Journal||Nucleic acids research|
|Date Published (YYYY/MM/DD)||2013/06/12|